Ligand/receptor-based chimeric antigen receptors: a promising alternative to conventional scFv designs in cancer immunotherapy
Alexei Valerievich YumashevDepartment of Prosthetic Dentistry, First Moscow State Medical University, Moscow, Russian Federation. Electronic address: [email protected]Zumrad ErgashevaDepartment of Internal Medicine, Andijan State Medical Institute, Andijan, UzbekistanOzimbay JabbarovDepartment of Faculty and Hospital Therapy, Nephrology and Hemodialysis, Tashkent State Medical University, Tashkent, UzbekistanAbdulatif SanakulovDilovar KarshiyevaDepartment of Hygiene No.2, Bukhara State Medical Institute named after Abu Ali Ibn Sino, Bokhara, UzbekistanDilorom NamozovaFergana State University, Fergana, UzbekistanZubaydillo NarziyevBukhara State Pedagogical Institute, Bokhara, UzbekistanRanohon GulomovaDepartment of Obstetrics and Gynecology, Fergana Medical Institute of Public Health, Fergana, UzbekistanZarina KhalbayevaDepartment of Medicine, Termez University of Economics and Service, Termez, Uzbekistan
2026en
Ochiq kirish: yoʻq
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos112 ta foydalanilgan manba